Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 2, 2025International Journal of Molecular Medicine

Histone deacetylase 4: A therapeutic target for cardiovascular diseases (Review)

View Full Paper
Ask AI
Bookmark
Share

Authors

XMXiaotong MaRWRan WeiASAnni Song

Discussion

Loading...

Member takes

Overview

Review shows that histone deacetylase 4 influences cardiovascular disease progression, suggesting new therapeutic strategies.

Key Points

  • Histone deacetylase 4 plays a pivotal role in the development of cardiovascular diseases such as hypertension and atherosclerosis.
  • Studies indicate that HDAC4 regulates critical processes like inflammation, fibrosis, and apoptosis in CVD.
  • The review highlights the potential therapeutic effects of pharmacological agents and exercise on HDAC4 expression.
  • Future research is essential to uncover the molecular mechanisms of HDAC4 in cardiovascular diseases for better treatment strategies.

Cite This Study

Ma et al. (2025) studied this question.

synapsesocial.com/papers/689a0c7be6551bb0af8d0496https://doi.org/10.3892/ijmm.2025.5599
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Apoptosis dysfunction: unravelling the interplay between ZBP1 activation and viral invasion in innate immune responses2024 · 24 citations
  2. 2Joint association of TyG index and high sensitivity C-reactive protein with cardiovascular disease: a national cohort study2024 · 190 citations
  3. 3Increased Oxidative Stress in the Nucleus Caused by Nox4 Mediates Oxidation of HDAC4 and Cardiac Hypertrophy2012 · 188 citations
  4. 4CaMKIIδC Drives Early Adaptive Ca 2+ Change and Late Eccentric Cardiac Hypertrophy2020 · 61 citations
  5. 5Quercetin inhibits necroptosis in cardiomyocytes after ischemia–reperfusion via DNA‐PKcs‐SIRT5 ‐orchestrated mitochondrial quality control2024 · 129 citations